Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -89.8% | -81.2% | 0 / 3 | -55.3% | +1.97 pp | -0.03 pp | +2.0% | 0.48 | 12.07 | 49,2 | −55,3% | 0,0 | −66,8% | 12.07 | 15.87 | −24,0% |
| Pts | 0 | 0 | 0 | 0 | 8 | 4 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 4.410 (close price on 2026-10-16)EPS (TTM): 365,5
Financial charts
1.Revenue & growth
VND bn49,2Q2/26
1.Revenue & growth
VND bn49,2Q2/26
2.Profit & growth
VND bn0,03Q2/26
3.Profit mix (Penman)
VND bn5,64Q2/26
4.Margins & cost structure
%6.4%Q2/26
5.Returns & cash cycle
% · days1.9%Q2/26
6.Earnings quality & cash
VND bn101Q2/26
7.Asset structure
VND bn626Q2/26
8.Funding & debt health
VND bn · times626Q2/26
9.Revenue backlog
VND bn21,9Q2/26
10.Valuation
times · %30,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1Q2/26
Adjusted EPS growth, latest quarter
-89.8%
Average adjusted EPS growth, 3 quarters
-81.2%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
150%
Source: vnstockData through Q2/26